Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
67.355,04
0,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Anixa Biosciences Inc (ANIX) Anixa Biosciences Inc (ANIX) Notizie

ANIX

Anixa Biosciences (ANIX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANIX
DataOraFonteTitoloSimboloCompagnia
08/05/202414:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
08/05/202414:25PR Newswire (US)Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer VaccinesNASDAQ:ANIXAnixa Biosciences Inc
06/05/202414:05PR Newswire (US)Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay JunejaNASDAQ:ANIXAnixa Biosciences Inc
30/04/202413:45PR Newswire (US)Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024NASDAQ:ANIXAnixa Biosciences Inc
18/04/202414:20PR Newswire (US)Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
14/03/202413:45PR Newswire (US)Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested PartiesNASDAQ:ANIXAnixa Biosciences Inc
11/03/202413:00PR Newswire (US)Anixa Biosciences Announces Presentation at 24th Annual World Vaccine CongressNASDAQ:ANIXAnixa Biosciences Inc
12/02/202413:30PR Newswire (US)Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
08/02/202422:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANIXAnixa Biosciences Inc
29/01/202414:50PR Newswire (US)Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology ConferenceNASDAQ:ANIXAnixa Biosciences Inc
23/01/202413:55PR Newswire (US)Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
17/01/202401:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
16/01/202423:29Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIXAnixa Biosciences Inc
16/01/202422:43Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIXAnixa Biosciences Inc
16/01/202422:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIXAnixa Biosciences Inc
10/01/202415:00PR Newswire (US)Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024NASDAQ:ANIXAnixa Biosciences Inc
14/12/202313:15PR Newswire (US)Anixa Biosciences to Present at Biotech Showcase 2024NASDAQ:ANIXAnixa Biosciences Inc
07/12/202300:00PR Newswire (US)Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
06/12/202322:05PR Newswire (US)Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
27/11/202314:30PR Newswire (US)Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
31/10/202313:30PR Newswire (US)Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National ConferenceNASDAQ:ANIXAnixa Biosciences Inc
23/10/202314:30PR Newswire (US)Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
13/10/202314:30PR Newswire (US)Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
03/10/202314:30PR Newswire (US)Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
19/09/202314:30PR Newswire (US)Anixa Biosciences Establishes Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
06/09/202322:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIXAnixa Biosciences Inc
31/08/202314:30PR Newswire (US)Anixa Biosciences to Participate in September Investor ConferencesNASDAQ:ANIXAnixa Biosciences Inc
28/08/202314:30PR Newswire (US)Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
14/08/202314:30PR Newswire (US)Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR SummitNASDAQ:ANIXAnixa Biosciences Inc
07/08/202314:30PR Newswire (US)Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANIX

La tua Cronologia

NASDAQ
HCCCU
Healthcare Capital
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network